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Abstract
 Smartphone applications (apps) are popular aids for smokingBackground:
cessation. Smoke Free is an app that delivers behaviour change techniques
used in effective face-to-face behavioural support programmes. The aim of this
study was to assess whether the full version of Smoke Free is more effective
than the reduced version.
  This was a two-arm exploratory randomised controlled trial.Methods:
Smokers who downloaded Smoke Free were randomly offered the full or
reduced version; 28,112 smokers aged 18+ years who set a quit date were
included. The full version provided updates on benefits of abstinence, progress
(days smoke free), virtual ‘badges’ and daily ‘missions’ with push notifications
aimed at preventing and managing cravings. The reduced version did not
include the missions. At baseline the app recorded users’: device type (iPhone
or Android), age, sex, daily cigarette consumption, time to first cigarette of the
day, and educational level. The primary outcome was self-reported complete
abstinence from the quit date in a 3-month follow-up questionnaire delivered via
the app. Analyses conducted included logistic regressions of outcome on to
app version (full versus reduced) with adjustment for baseline variables using
both intention-to-treat/missing-equals smoking (MES) and follow-up-only (FUO)
analyses.
 The 3-month follow-up rate was 8.5% (n=1,213) for the interventionResults:
and 6.5% (n=901) for the control. A total of 234 participants reported not
smoking in the intervention versus 124 in the control, representing 1.6% versus
0.9% in the MES analysis and 19.3% versus 13.8% in the FUO analysis.
Adjusted odds ratios were 1.90, 95%CI=1.53-2.37 (p<0.001) and 1.50,
95%CI=1.18-1.91 (p<0.001) in the MES and FUO analyses respectively.
 Despite very low follow-up rates using in-app follow up, bothConclusions:
intention-to-treat/missing equals smoking and follow-up only analyses showed
the full version of the Smoke Free app to result in higher self-reported 3-month
continuous smoking abstinence rates than the reduced version.
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Introduction
Smartphone applications (apps) are used by many smok-
ers to aid cessation but currently little evidence exists on their 
effectiveness. The Smoke Free app (smokefreeapp.com) is very 
popular worldwide, with some 4,000 new downloads per day. 
When it first became available, it was the subject of a trial with 
users finding and downloading the app from the app store being 
randomly assigned to a full version or a reduced version. This 
provided an opportunity to assess whether the full version was 
more effective than the reduced version in an effectiveness study 
closely mirroring the real-world scenario of interest. This paper 
reports the findings from that trial.
The Smoke Free app was developed using behaviour change 
techniques (BCTs) found in effective behavioural support 
programmes for smoking cessation1. A description of the app 
is given in Supplementary File 1. The evidence-based BCTs 
implemented in the full version of the app were: 1) Supporting 
identity change: supporting app users to think of themselves as 
non-smokers, 2) Rewarding abstinence: praise, virtual prizes and 
showing them how much money they are saving each day of not 
smoking, 3) Changing routines: advising on ways of avoiding 
smoking cues by changing routines that involve smoking, and 
4) Advising on medication use: promoting the use of one of 
the evidence-based stop-smoking medicines. These BCTs are 
designed to increase resolve and prevent, reduce and counter 
urges to smoke.
Behavioural support delivered via a smartphone could help 
smokers to stop. Internet-based support has been found in some 
cases to aid cessation2 and smartphone apps can provide this 
functionality with the added advantage of being readily acces-
sible at almost any time. Two prospective studies of users of 
smoking cessation apps3,4, a randomised controlled trial (RCT) 
comparing an app with a text messaging intervention5 and two 
RCTs comparing mindfulness-based apps with other apps6,7 
found self-reported success rates that were higher than would 
be expected from unaided cessation. One RCT has found that an 
app acting as a decision aid for smokers interested in stopping 
smoking resulted in higher 6-month abstinence rates than an infor-
mation-only app8. Another RCT examined the effectiveness of a 
set of app components as an aid to cessation in pregnant smok-
ers; engagement with the app was low and no specific compo-
nents were found to increase short-term self-reported abstinence 
rates9. To date, no RCTs have been published comparing apps 
designed to provide ongoing support for quit attempts with 
unaided quitting, or more intensive versus less intensive versions 
of an app.
Evaluating the effectiveness of smoking cessation apps versus 
unaided cessation in RCTs is complicated by the fact that apps 
are widely available and participants who are randomised to the 
unaided quitting condition are likely to be motivated to drop 
out of the study or use one of the many freely available apps. 
An alternative is to compare full and reduced versions of an 
app in which the reduced version is sufficiently credible that 
participants who are randomised to receive it are not motivated 
to drop out of the study or seek out another app. That was the 
approach used in the present study.
Another challenge for RCTs of apps is how to address the 
problem of loss to follow up. With sufficient resources, high 
follow-up rates can be obtained in such trials6,10. However, the 
methods used can lead to problems of generalizability; study 
engagement processes that involve face-to-face visits, incen-
tives and contracts on the part of participants that may exclude 
a substantial proportion of the target population. Moreover, 
the resources required are prohibitive for the kind of agile, 
iterative evaluation that is required during the development 
of these interventions, where evaluations need to be under-
taken repeatedly11. Automated outcome assessment using the 
smartphone is low cost and does not require procedures that 
may undermine generalizability. Despite the fact that it may 
result in very low follow-up rates that is the approach used in the 
current study.
In smoking cessation trials it is common practice to use an 
intention-to-treat approach with participants lost to follow up 
considered to have resumed smoking12. This may bias effect 
sizes downwards if loss to follow up occurs for reasons other 
than relapse to smoking13. Conversely, it may bias effect sizes 
upwards if the intervention condition leads to higher follow-
up rates than the control condition. Only including participants 
who are successfully followed up may overestimate absolute 
success rates if participants refuse to engage with follow up 
because they have resumed smoking, but this would not affect 
the odds ratio comparing two conditions since this bias would 
affect both intervention and comparison groups equally. This 
approach is also immune to bias caused by differential follow-up 
in intervention and control groups. In practice ‘missing equals 
smoking’ (MES) and ‘follow-up only’ (FUO) approaches tend to 
produce very similar odds ratios in smoking cessation RCTs14, 
though the percentage point difference between conditions varies 
considerably. Multiple imputation methods are increasingly 
being used to estimate values for missing data arising from loss 
to follow up (e.g. Westmaas et al.15). However, these are only 
viable when the proportion of values that are missing is low. To 
address biases arising from loss to follow up, both the MES 
and FUO approaches were used in the present study. It may be 
expected that the true percentage point difference and odds ratios 
lie somewhere between the estimates provided by these two 
methods.
            Amendments from Version 1
The revised version highlights in the title and abstract that the trial 
was exploratory because it was not pre-registered. It also clarifies 
the rationale for the intervention, and a number of methodological 
issues. We also make clearer that including both intention-to-
treat and follow-up only analyses addresses the weaknesses of 
each of these two methods; the first ensures that quit rates are 
not overstated as a result of selection bias at follow-up, and the 
latter removes the risk that the results arise from those in the 
intervention group being more likely to be followed up. 
See referee reports
REVISED
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Biochemical verification of abstinence is recommended in 
smoking cessation trials because of psychological pressure to 
claim abstinence12. However, this is highly resource intensive 
and may undermine generalizability to smokers who would use 
an app but not a more intensive interaction. such as this with no 
personal contact with a counsellor there may be expected to 
be no greater psychological pressure on participants to falsely 
claim abstinence in one condition than another’ so reliance on 
self-reported abstinence should not bias the estimated effect size. 
Therefore, this study used self-report for outcome assessment.
Duration of follow up is an important consideration in smoking 
cessation trials. Conventionally, follow-up at least 6 months 
after the start of an intervention is considered appropriate for 
definitive trials while shorter durations are acceptable for proof 
of concept trials12. A recent systematic review of continuous 
abstinence rates in smoking cessation trials has recently found, 
however, that rates at 6-month and 12-month follow up can be 
accurately predicted from findings after 12 weeks16. Loss to 
follow up may be greater with longer follow up so in the 
present study participants were followed up 12 weeks after the 
target quit date.
Thus, this study addressed the question of whether the full 
version of the Smoke Free app would result in higher 12-week 
self-reported continuous abstinence rates than a reduced version of 
the app in smokers downloading the app and using it to set a quit 
date.
Methods
Study design
Participants were individually randomly allocated by the app on 
a 1:1 ratio to the full or reduced version and followed up auto-
matically by the app 12 weeks after the target quit date to assess 
the outcome. Randomisation was by a random number generator 
in the app and generated a 1 or 2 during the registration process 
independently for each user. This study was not pre-registered 
because the lead author was not aware of this requirement at the 
time the data were collected, and so the study must be considered 
exploratory. We used the CONSORT-SPI checklist in preparing 
this report17 (Supplementary File 2). The study was approved 
by the University of East London Ethics Committee.
Participants
Participants were not actively recruited and received no 
financial incentive for taking part. Smokers who downloaded 
the Smoke Free app between February 2013 and January 2015 
were informed by the app that it was being used in an evalu-
ation and asked for permission to use their data for research 
purposes. The app was available globally but only in the English 
language. If participants agreed they completed baseline meas-
ures and were randomly assigned by a computer-generated ran-
dom number sequence to be offered a full or reduced version of 
the app. Consent was given by users by means of the touchscreen 
on their device. They were then included in the analysis if they 
met the following criteria: aged 18 years or over, smoked ciga-
rettes at the time of registration (whether daily or non-daily), 
set only one quit date, and used the app at least once 
on or after their target quit date. Those users who had started 
their quit attempt before the date of registration were excluded, 
and if users registered more than once on the same device 
(as identified by the device ID) only data from the first 
registration was used.
Participants were aware that they were taking part in an experi-
ment but were not aware of the details of the condition to which 
they had not been assigned.
Sample size was determined pragmatically by recruiting from 
the point where the app was in a form that was stable to the 
deadline for delivery of the lead author’s project report. A 
total of 28,112 participants were included in the sample, of 
whom 14,228 received the full version and 13,884 received the 
reduced version.
Intervention and comparator
The full version of the Smoke Free app took smokers through 
the first month of their quit attempt by helping them maintain 
their resolve by setting a clear goal, monitor their progress 
towards that goal and become aware of benefits achieved to 
date. There were several components: 1) a calculator that tracked 
the total amount of money not spent on buying cigarettes and 
the number of cigarettes not smoked; 2) a calendar that tracked 
the amount of time elapsed since cessation; 3) a scoreboard that 
awarded virtual ‘badges’ to users for not smoking; 4) progress 
indicators that informed users of health improvements expected 
since the start of their quit attempt; and 5) daily missions 
that were assigned from the start of a user’s quit date for one 
calendar month.
The daily missions included behaviour change techniques 
that research has suggested are likely to improve the chances 
of avoiding and resisting cravings and thereby promote 
abstinence18–20. A list of the daily missions can be found in the 
Supplementary File 1.
The full version of Smoke Free received daily push notifi-
cations for one calendar month from the start of their quit 
date. Users were prompted to open the app to read each day’s 
mission. The time of the push notification was preset to 8am 
local time but this could be changed to a time of the user’s 
preference. For screenshots of the app see Supplementary 
File 1.
The reduced version of the app was the same as the full version 
but without the daily missions.
Measures
After consenting to take part in the experiment, users were 
asked to provide information on their: age, sex, educational 
level (high school or secondary school, undergraduate degree, 
or post-graduate degree), daily cigarette consumption, and 
time to first cigarette of the day (<5 minutes, 5–30 minutes, 
31–60 minutes, >60 minutes)21.
After filling out the baseline questionnaire, users were then 
requested to record their target quit date which could be any 
date in the past or future (with those having already quit being 
excluded from the analysis).
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Table 1. Baseline characteristics of the study sample.
Variable Reduced 
version
Full version Total
Device type:
  Android, N (%) 1,075 (7.7) 1,044 (7.3) 2,119 (7.5)
  iOS, N (%) 12,809 (92.3) 13,184 (92.7) 25,993 (92.5)
Age, mean years (SD)* 29.1 (9.4) 28.7 (9.0) 28.9 (9.2)
Sex
  Female, N (%) 6,769 (48.8) 7,015 (49.3) 13,784 (49.0)
  Male, N (%) 7,115 (51.2) 7,213 (50.7) 14,328 (51.0)
Educational level
  School only, N (%) 8,734 (62.9) 8,949 (62.9) 17,683 (62.9)
  Undergraduate, N (%) 3,477 (25.0) 3,598 (25.3) 7,075 (25.2)
  Postgraduate, N (%) 1,673 (12.0) 1,681 (11.8) 3,354 (11.9)
Quit date
  Day of registration, N (%) 9,514 (68.5) 9,915 (69.7) 19,429 (69.1)
  After registration, N (%) 4,370 (31.5) 4,313 (30.3) 8,683 (30.9)
Cigarettes per day, mean (SD)* 14.8 (7.6) 14.6 (7.4) 14.7 (7.5)
Time to first cigarette*
  <6 minutes, N (%) 3,679 (26.5) 3,569 (25.1) 7,248 (25.8)
  6–30 minutes, N (%) 4,374 (31.5) 4,350 (31.8) 8,904 (31.7)
  31–60 minutes, N (%) 2,788 (20.1) 2,896 (20.4) 5,684 (20.2)
  >60 minutes, N (%) 3,043 (21.9) 3,233 (22.7) 6,267 (22.3)
*p<0.05 for comparison between groups, not adjusted for number of comparisons.
The primary outcome measure was self-reported continuous 
abstinence up to 12-week follow-up. The app sent users a 
push notification 12 weeks after the target quit date ask-
ing them to open the app and respond to a questionnaire. The 
app did not send reminder notifications. The questionnaire 
asked: 1) “Have you smoked at all in the last three months?” to 
which they could respond: “No, not a puff”, “1–5 cigarettes”, or 
“More than 5 cigarettes”. Those who responded “not a puff” were 
considered to be abstinent.
Analysis
Baseline characteristics of the two groups were compared 
using chi-squared tests or analyses of variance as appropriate. 
Outcomes were compared using logistic regression analyses 
with and without adjusting for all baseline variables. Two 
analytic approaches were used: 1) MES in which smokers who 
were lost to follow-up were counted as having smoked, and 
2) FUO in which only smokers who responded to the 3-month 
follow-up were included in the analysis. Odds ratios and 95% 
confidence intervals were computed, along with p-values.
Data used in the analyses are available as Supplementary File 3 
as an SPSS file and the SPSS syntax used to run the analyses is 
provided in Supplementary File 4. The full data set, including 
variables not included in the analysis, are provided in 
Dataset 1.
Results
Table 1 shows participants’ baseline characteristics and 
Figure 1 shows the numbers allocated to each group and followed 
up. Participants who received the reduced version of the app 
were older, smoked more cigarettes per day, started smoking 
earlier in the day and were more likely to designate a quit date 
that was after the date of registration, but the differences were 
small. Complete data are shown in Dataset 122.
Of the participants, 2,114 (7.5%) were followed up (full ver-
sion 1,213, 8.5%, reduced version 901, 6.5%). In the MES 
analysis 1.6% (n=234) of the participants in the intervention 
group and 0.9% (n=124) of the participants in the control group 
reported as being abstinent from smoking (unadjusted Odds 
ratio=1.86; 95% CI=1.49-2.31; p<0.001; risk difference 0.7%). 
In the FUO analysis, 19.3% in the intervention group and 
13.8% in the comparison group reported being abstinent 
(unadjusted Odds Ratio=1.50; 95% CI=1.18-1.90; p<0.001; risk 
difference 5.5%).
Table 2 shows the results from logistic regression analyses with 
app version and all baseline variables entered together. In both 
the MES and FUO analyses, participants randomized to the full 
version of the app had higher odds of reporting successful 
abstinence with odds ratios almost identical to the unadjusted 
regression analyses. A number of baseline variables also 
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Table 2. Results of adjusted logistic regression analyses of 
outcome on to treatment group and baseline variables.
Predictor variable Missing equals 
smoking 
analysis
Follow-up only 
analysis
Treatment group
  Reduced version Reference Reference
  Full version 1.90 (1.52-2.37)* 1.50 (1.18-1.91)*
Device type
  iOS Reference Reference
  Android 0.25 (0.12-0.50)* 0.29 (0.14-0.60)*
Age, years 1.05 (1.04-1.06)* 1.03 (1.02-1.04)*
Sex
  Male Reference Reference
  Female 1.23 (0.99-1.52) 1.00 (0.79-1.27)
Educational level
  School only Reference
  Undergraduate 1.06 (0.83-1.35) 0.93 (0.71-1.22)
  Postgraduate 1.01 (0.73-1.39) 1.10 (0.77-1.58)
Quit date
  Day of registration Reference Reference
  After registration 0.43 (0.33-0.57)* 0.69 (0.51-0.93)*
Cigarettes per day 1.01 (1.00-1.03) 1.00 (0.99-1.02)
Time to first cigarette
  <6 minutes Reference Reference
  6–30 minutes 1.61 (1.21-2.14)* 1.36 (0.99-1.86)
  31–60 minutes 1.53 (1.10-2.15)* 1.19 (0.82-1.73)
  >60 minutes 1.27 (0.88-1.83) 0.99 (0.66-1.48)
*p<0.05 for linear trend or comparison with reference.
Figure 1. Flow of participants.
predicted reported abstinence. Older participants were more 
likely to report abstinence, while those using Android (versus iOS 
devices) and those whose quit date was after (versus on) the 
date of registration were less likely to report abstinence. In the 
MES analysis, participants whose first cigarette of the day was 
more than 5 minutes from waking were more likely to remain 
abstinence that those who smoked within 5 minutes of waking, 
but the difference was not statistically significant for those 
smoking their first cigarette more than 60 minutes from waking.
Dataset 1. Full de-identified data from each study participant, 
including download dates, quitting dates and all other data 
input into the app
https://dx.doi.org/10.5256/f1000research.16148.d218541
Discussion
In both the MES and FUO analyses the full version of the 
Smoke Free app produced higher self-reported abstinence rates 
than the reduced version 12 weeks after the target quit date. 
The odds ratios were 1.86 and 1.50 in the MES and FUO 
analyses respectively, and the percentage point differences 
between full and reduced versions were 5.5% and 0.7%.
Even with very low follow-up rates the study found a small 
but clear advantage to the full version of the app which may be 
attributed to the inclusion of the daily missions. The effect size 
in terms of odds ratios was similar to, or slightly lower, than 
was found in the only published RCT to date to have found a 
clear effect of a smoking cessation app. This effect is on top of 
whatever effect the reduced version of the app may have had. 
Even in the follow-up only analysis the abstinence rates were 
relatively low, and lower than is found in studies involving 
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Supplementary material
Supplementary File 1. Details on the Smoke Free app, including each day’s mission.
Click here to access the data.
Supplementary File 2. Completed CONSORT-SPI checklist.
Click here to access the data.
Supplementary File 3. Data used in the analyses.
Click here to access the data.
Supplementary File 4. SPSS command syntax for the analyses.
Click here to access the data.
face to face support or pharmacotherapy23. Therefore, this app 
should not be regarded as a substitute for those forms of sup-
port. It is possible that this app could increase abstinence rates in 
smokers using such forms of support but this remains to be 
tested.
The fact that an intervention effect was found in the FUO 
analyses indicates that it was not due to bias arising from dif-
ferential loss to follow up. The fact that adjusting for baseline 
variables that are predictive of successful cessation did not 
influence the odds ratios adds confidence that the results were 
not due to smokers who found it easier to stop being more likely 
to be followed up in the intervention condition.
The lower success rate in participants using Android versus 
iOS devices needs to be investigated further. It was not explained 
by other baseline characteristics measured in this study. It may 
reflect the fact that Android users tend to have lower 
socioeconomic position or it could be that some of the devices 
do not have as high usability, e.g. in terms of screen size or 
resolution.
Strengths of the current study are the large sample size, the fact 
that it assessed an app that is very popular and therefore needs 
to be evaluated, and high generalizability to the population of 
interest, i.e. smokers finding the app on apps stores. Limitations 
are the very low follow-up rate, use of self-reported abstinence, 
the relatively short follow-up duration and the absence of proc-
ess measures to assess what mediated the intervention effect. 
The generalisability of the study is limited by the low follow-up 
rate and to smokers who are willing to download an app such as 
this for help with stopping smoking.
Research continues into apps to support smoking cessation24–29, 
with improvements in technology providing new opportuni-
ties for intervention content, such as virtual reality and use of 
wearable devices. The popularity of the Smoke Free app should 
make it a useful vehicle for testing innovations in smoking ces-
sation support, building on the version of the app tested in 
this study. Research is needed into improving follow-up rates 
without compromising generalizability and within the resource 
constraints operating on companies and research groups seeking 
to build incrementally on app performance.
In conclusion, the full version of the Smoke Free smartphone app 
appears to have small effect in improving 12-week abstinence 
rates in smokers trying to quit. This provides a basis for building 
a programme of incremental improvement in effectiveness.
Data availability
Dataset 1. Full de-identified data from each study participant, 
including download dates, quitting dates and all other data 
input into the app. Data are available in SAV and CSV formats. 
DOI: https://doi.org/10.5256/f1000research.16148.d21854122.
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Fred Hutchinson Cancer Research Center,  Seattle, WA, USA
I accept their revision and have no further comments.
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Version 1
 23 October 2018Referee Report
https://doi.org/10.5256/f1000research.17634.r39534
 Jonathan Bricker
Fred Hutchinson Cancer Research Center,  Seattle, WA, USA
This manuscript reports on the results of a fully automated RCT that compared the Smoke Free app with
and without 30 days of behavior change technique skills for quitting and preventing relapse ("missions").
Major strengths:
The scientific premise of the study is strong. Determining the added value of behavior change
techniques for smoking cessation is useful in any context (not just apps) so the study affords a
real-world opportunity to test the techniques' potential effectiveness.
Testing the effectiveness of a widely utilized app in real-world conditions of consumers actually
downloading to help them quit smoking is valuable from the point of view of implementation
research. And perhaps that is the best context from which to frame this study--a real world
implementation study.
Novelty. There is a dearth of studies comparing apps for smoking cessation so the study adds to a
small and important literature.
Major weaknesses:
Trial was not registered. This is a very serious weaknesses that impacts ethical obligations to
participants, research community, and publication bias. Reputable journals would not even
consider reviewing this paper knowing that is was not registered. The authors are aware of this
Page 9 of 17
F1000Research 2019, 7:1524 Last updated: 22 JAN 2019
 1.  
2.  
1.  
2.  
consider reviewing this paper knowing that is was not registered. The authors are aware of this
weakness and I have no reason to believe they acted intentionally unethically. Nonetheless, it
would be appropriate not to title the study a randomized trial or use that term in the abstract.
Instead, I recommend the authors use the same term employed in methods section of the study
design: "Exploratory Study." The authors themselves call it that. Now they just need to make it
clear up front.
Very low retention rate (7.5%) that appears to imbalanced by a relative rate of 24% between arms.
This is a very unfortunate weakness that could have been avoided with some small and immediate
incentives given that only one question is asked in the follow-up survey. Nonetheless, it is what it
is. The level of bias from this extent of missing data (92.5%) cannot be overcome with imputation
methods. And the argument that the relative difference (not absolute quit rate) is what matters for
this study is undermined by the imbalanced retention rates. With 24% more data in one arm than
the other, it very possible that the difference in quit rates is simply driven by the difference in
retention rates.
Moderate weaknesses:
The main outcome of continuous abstinence after baseline is biased by differences in quit dates
and simply does not give people enough time to even reach their quit date before they would
already be counted a smoker. Thus, the actual quit rates could be higher. Its hard to say with this
outcome. 
Generalizablity is overstated for two reasons. The low retention rate makes the sample highly
biased toward the most motivated people who are most likely to be reporting that they quit.
Comparing the baseline characteristics of all those enrolled vs only those completed the outcome
survey item would be very important and instructive about bias. The second reason it is overstated
is that the sample is limited to those who have already chosen an app and this particular app to
help them quit smoking. The sample age (29) is young for a mhealth smoking study, which typically
is about age 40. 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Referee Expertise: mhealth for smoking cessation
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Author Response 08 Jan 2019
, University College London, UKRobert West
Major weaknesses
Trial was not registered. This is a very serious weaknesses that impacts ethical obligations
to participants, research community, and publication bias. Reputable journals would not
even consider reviewing this paper knowing that is was not registered. The authors are
aware of this weakness and I have no reason to believe they acted intentionally unethically.
Nonetheless, it would be appropriate not to title the study a randomized trial or use that term
in the abstract. Instead, I recommend the authors use the same term employed in methods
section of the study design: "Exploratory Study." The authors themselves call it that. Now
they just need to make it clear up front.
Response: We agree that the fact that the trial was not registered is a weakness. It does not affect
the weakness of this trial but we note that even now, large numbers of behavioural trials published
in high quality journals are not pre-registered. We gave a great deal of consideration before
submitting the first version as to whether to call this an RCT and in the end decided to do so
because that is what it was. We have checked authoritative definitions (e.g. the UK’s National
Institute for Health and Care Excellence) and they do not specify pre-registration in the definition.
As the reviewer acknowledges, we make it very clear that the trial was not pre-registered. We
believe that we must use the term RCT in the title etc but have added the word ‘exploratory’ to
highlight this issue.
Very low retention rate (7.5%) that appears to imbalanced by a relative rate of 24% between
arms. This is a very unfortunate weakness that could have been avoided with some small
and immediate incentives given that only one question is asked in the follow-up survey.
Nonetheless, it is what it is. The level of bias from this extent of missing data (92.5%) cannot
be overcome with imputation methods. And the argument that the relative difference (not
absolute quit rate) is what matters for this study is undermined by the imbalanced retention
rates. With 24% more data in one arm than the other, it very possible that the difference in
quit rates is simply driven by the difference in retention rates.
Response: We agree that the low follow up is a major weakness and prevents estimation of
absolute effect size. However, we disagree that the imbalance in follow-up rates could have
contributed to the relative effect. As we explain in the introduction, we conducted an additional
analysis only on those followed up and still got a highly significant effect with an odds ratio of 1.5.
We have explored the issue of whether results from the follow-up only sample can possibly be
affected by differential follow up rate and with both analytical reasoning and extensive modelling of
extreme difference we find that it cannot. We were initially surprised but once we saw it, it was
obvious. 
To help see this, imagine a study of 1000 smokers with 500 allocated to each group. Then imagine
200 (40%) are followed-up in the intervention group and 100 (20%) in the control group. Imagine
that in fact there is no difference in effect between the conditions so 50 (10%) are actually
abstinent in each group. In an intent to treat analysis with missing equals smoking we would expect
20 (40% of 50) successes in the intervention group and 10 (20% of 50) in the control group which
would translate to 20/500=4% in the intervention group versus 10/500=2% in the control group –
apparently double the success rate in the intervention than control group which is clearly wrong.
But in the follow-up only analysis the figures are 20/200=10% in the intervention group and
10/100=10% in the control group – correctly showing no effect. You can try this with any
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But in the follow-up only analysis the figures are 20/200=10% in the intervention group and
10/100=10% in the control group – correctly showing no effect. You can try this with any
permutation of outcomes and it always comes out the same.
Moderate weaknesses
The main outcome of continuous abstinence after baseline is biased by differences in quit
dates and simply does not give people enough time to even reach their quit date before they
would already be counted a smoker. Thus, the actual quit rates could be higher. Its hard to
say with this outcome. 
Response: We agree that the actual quit rates may well be higher. In fact, given what we observe
in prospective studies of unaided quitting it would be surprising if the quit rates were not higher. We
were not sure what the reviewer was referring to when saying that some participants may not have
reached their quit dates by the follow up; the follow up was always 12 weeks after their designated
quit date.
Generalizablity is overstated for two reasons. The low retention rate makes the sample
highly biased toward the most motivated people who are most likely to be reporting that they
quit. Comparing the baseline characteristics of all those enrolled vs only those completed
the outcome survey item would be very important and instructive about bias. The second
reason it is overstated is that the sample is limited to those who have already chosen an app
and this particular app to help them quit smoking. The sample age (29) is young for a
mhealth smoking study, which typically is about age 40. 
Response: We now note in the discussion that the generalizability of the findings is limited by the
low follow-up rate and to smokers. However, it should be noted that in the intention to treat analysis
the sample was not limited to those followed up and the odds ratio was slightly higher than for the
follow-up only sample and adjusting for baseline variables that are predictive of successful
cessation also did not influence the finding. The data are available for anyone who would like to
compare the baseline characteristics of those followed-up compared with who were not.  
 No competing interests were disclosed.Competing Interests:
 08 October 2018Referee Report
https://doi.org/10.5256/f1000research.17634.r38627
 Erica Cruvinel
Preventive Medicine and Public Health Department, University of Kansas Medical Center, Kansas City,
Kansas, USA
This manuscript is a study of the “Relative effectiveness of a full versus reduced version of the ‘Smoke
Free’ mobile application for smoking cessation: a randomised controlled trial”. The use of such
applications as described therein can extend the reach of smoking cessation interventions to a large
number of smokers through low-cost approaches. Thus, the results of this study will be of great interest to
the tobacco treatment community. I have several questions about the details of the study and some
suggested edits. 
Introduction:
The introduction discusses most methodology decisions, such as those about the comparator group,
follow up loss, analysis, and the measure of abstinence. But, it lacks some conceptual information. For
instance, it does not address why the full version of the app was expected to be more effective than the
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 instance, it does not address why the full version of the app was expected to be more effective than the
reduced version. I would like to see a more conceptual description used as a background to support the
development of an extended version beyond the app’s basic version. Also, I think methodology decisions
would fit better under methods or study limitations. In addition, it is not clear what the authors mean by,
“Also, in a trial where there is no greater psychological pressure to claim abstinence in one condition than
another, use of self-report should not bias the estimated effect size“. I’m not sure if the authors refer to a
non-superiority trial since the last sentence in the introduction session shows that they expected a better
result in the intervention group. 
Furthermore, I would like to have more information about the app itself. For instance, are people from all
over the world able to download the app? In which languages is it available?
Methods:
Study design:
Provide more details about the method used to generate the random allocation sequence (such as
blocking and block size). 
Participants:
Were included daily and occasionally smokers? In which countries do the participants reside? Is the app
only in English?
Intervention and comparator 
Show the theory that guided the development of these interventions in this section. 
Measures:
Did you collect data about how often the app was used and for how long?
Analysis:
How did you control against the duplication of data, such as if someone installed the app twice? 
What strategy did you use to increase follow up response rates? Did you set up a reminder function to
send notifications to the user to complete the follow-up questionnaire?
How did you handle missing data? (details of any imputation method)
Results:
How did the participants use the app? If you included descriptive information from both groups, then it
would help us to better understand participant interactions with the app.
Did you have information about whether participants used other methods to quit smoking? For instance,
nicotine replacement therapy?
The sentence “Older participants, and in the MES analysis, those with longer time to their first cigarette of
the day were more likely to report abstinence”. This interpretation is confusing because the results from
participants who smoke cigarettes longer than 60 minutes were not significant. Also, those whose quit
date was after the date of registration were less likely to report abstinence. What was the comparator?
Table 2: It is not clear. What is the reference in table 2? 
Discussion:
The fifth sentence of the introduction states: “The odds ratios ranged between 1.50 and 1.90 in the two
analyses and the percentage point differences ranged between 0.7% and 5.5%”. Is it not 0.85 and 0.7? 
The last sentence in the third paragraph is not clear when looking at table 2. Which variable measured the
difficulty of quitting?
The quit rate in this study was lower compared to other studies (ex: BinDhim, McGeechan, Trevena, 2018
), as well as the follow-up rates. I would like to see more discussion about how the results from this study
compare to those of other apps.
The results showed that those using Android (versus iOS devices) were less likely to report abstinence.
What’s the implication of this data?
1
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Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Yes
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Partly
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Partly
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Referee Expertise: Smoking cessation, substance abuse
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Author Response 08 Jan 2019
, University College London, UKRobert West
The introduction does not address why the full version of the app was expected to be more
effective than the reduced version. I would like to see a more conceptual description used
as a background to support the development of an extended version beyond the app’s basic
version.
Response: We have now added this to the introduction and made reference to a paper that gives
more detail.
Methodology decisions would fit better under methods or study limitations.
 Response: We thought of doing this but in the end decided to keep it where it is because it made
the methods section harder to follow and is part of the rationale for the study rather than what was
actually done.
It is not clear what the authors mean by, “Also, in a trial where there is no greater
psychological pressure to claim abstinence in one condition than another, use of self-report
should not bias the estimated effect size“. I’m not sure if the authors refer to a
non-superiority trial since the last sentence in the introduction session shows that they
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non-superiority trial since the last sentence in the introduction session shows that they
expected a better result in the intervention group. 
Response: We obviously didn’t make this point clear. We were referring to the pressure that
respondents might feel to falsely claim that they were abstinent. We have reworded this to try to
make it clearer.
I would like to have more information about the app itself. For instance, are people from all
over the world able to download the app? In which languages is it available?
Response: We have now added this information. It is available globally but only in the English
language.
Provide more details about the method used to generate the random allocation sequence
(such as blocking and block size). 
Response: We now included this information. The app generated a random number (1 or 2) with
equal probability during the registration process for each user.
Were included daily and occasionally smokers?
Response: As indicated in the paper all smokers were included. We now make it explicit that this
included non-daily smokers.
Show the theory that guided the development of these interventions in this section. 
Response: We now include this in the explanation as to why we thought the full intervention would
be more effective than the reduced version.
Did you collect data about how often the app was used and for how long?
Response: We did not collect information about number of times the app was used, unfortunately.
How did you control against the duplication of data, such as if someone installed the app
twice?
Response: We already explain that if the app was downloaded more than once on the same
device, we used the first occurrence only. Please see page no 5, paragraph 4 (continued on page
6).
 
What strategy did you use to increase follow up response rates? Did you set up a reminder
function to send notifications to the user to complete the follow-up questionnaire?
Response: We already explain that push notifications appeared on the home screen of the device
to solicit responses to the follow up questionnaire. We now make clear that reminders were not
sent. Please see page no 7, paragraph 4.
How did you handle missing data (details of any imputation method)?
Response: We attempted to make this clear in the paper. We used both the traditional ‘missing
equals smoking’ method and follow-up only. The aim was to address different types of bias that
may arise from these two methods. As noted by reviewer 1, more sophisticated imputation
methods would have required much greater follow-up rates.
How did the participants use the app? If you included descriptive information from both
groups, then it would help us to better understand participant interactions with the app.
Response: Unfortunately we do not have this information.
Did you have information about whether participants used other methods to quit smoking?
For instance, nicotine replacement therapy?
Response: Unfortunately not. It possible that participants in the intervention group used other
methods to help them quit and indeed part of the effect of the app may have been to get them to do
so since advice on medication use was one of the behaviour change techniques used.
The sentence “Older participants, and in the MES analysis, those with longer time to their
first cigarette of the day were more likely to report abstinence”. This interpretation is
confusing because the results from participants who smoke cigarettes longer than 60
minutes were not significant.
Response: We have rephrased this to make clear that the association was only statistically
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Response: We have rephrased this to make clear that the association was only statistically
significantly for the middle two categories of time to first cigarette.
Also, those whose quit date was after the date of registration were less likely to report
abstinence. What was the comparator?
Response: We now make clearer that the comparator was those whose quit date was the same as
the date of registration.
Table 2: It is not clear. What is the reference in table 2?
Response: This is the standard way to report results from logistic regression analyses with
categorical independent variables. The ‘reference’ is the group against which the other groups are
compared.
The fifth sentence of the introduction states: “The odds ratios ranged between 1.50 and 1.90
in the two analyses and the percentage point differences ranged between 0.7% and 5.5%”.
Is it not 0.85 and 0.7?
Response: We think the reviewer means the second sentence in the discussion but were still not
sure what to make of this comment. This sentence just summarises the results from the
comparison between the intervention and comparator conditions as stated in the results. However,
to make this clearer we have rephrased this sentence.
The last sentence in the third paragraph is not clear when looking at table 2. Which variable
measured the difficulty of quitting?
Response: We now make clearer that this was based on using baseline variables that predicted
abstinence.
The quit rate in this study was lower compared to other studies (ex: BinDhim, McGeechan,
Trevena, 2018), as well as the follow-up rates. I would like to see more discussion about
how the results from this study compare to those of other apps.
Response: As noted by Reviewer 1, the follow-up rate was too low to be able to gain an accurate
estimate of absolute quit rates. However, we now included discussion of how the results compare
with those of previous RCTs of smoking cessation apps.
The results showed that those using Android (versus iOS devices) were less likely to report
abstinence. What’s the implication of this data?
Response: We now include a brief discussion of this finding.
 No competing interests were disclosed.Competing Interests:
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